tiprankstipranks
Trending News
More News >
Genmab A/S (DE:GE9)
XETRA:GE9

Genmab A/S (GE9) Similar Stocks

Compare
13 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Genmab A/S
€284.60
kr17.50B
13.29
41.24%
4 Buy
2 Hold
1 Sell
Moderate Buy
Genmab A/S
kr2116.08
kr130.75B
13.24
40.37%
4 Buy
2 Hold
1 Sell
Moderate Buy
GlaxoSmithKline
1805.50p
£72.84B
13.35
40.40%
3 Buy
8 Hold
3 Sell
Hold
AstraZeneca
13674.00p
£211.99B
29.45
33.56%
12 Buy
2 Hold
1 Sell
Moderate Buy
Hikma Pharmaceuticals
1533.00p
£3.38B
11.83
-20.08%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:GE9
Genmab A/S
284.60
83.10
41.24%
GB:0MGB
Genmab A/S
2,116.08
608.58
40.37%
GB:GSK
GlaxoSmithKline
1,805.50
519.57
40.40%
GB:AZN
AstraZeneca
13,674.00
3,435.68
33.56%
GB:HIK
Hikma Pharmaceuticals
1,533.00
-385.20
-20.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts